Longevity & Anti-Aging Biotech
Investment trends and scientific developments in anti-aging biotechnology, including regulatory risks and efficacy debates.
2 events tracked
- Single source8 days ago
Affluent individuals invest heavily in longevity treatments despite medical skepticism
Wealthy Americans spend up to $250,000 annually on longevity care; doctors weigh in on efficacy.
CNBC
- Single source10 days ago
Biotech investment in anti-aging races past scientific validation
Longevity science claims are outpacing evidence, raising questions about biotech and healthcare investment validity.
Al Jazeera